ZGNX Zogenix, Inc.

10.20
-0.25  -2.39%
Previous Close 10.45
Open 10.45
Price To book 1.83
Market Cap 252.86M
Shares 24,790,000
Volume 216,817
Short Ratio 13.30
Av. Daily Volume 280,306

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 initiation of efficacy portion announced February 13, 2017.
ZX008 - Study 1504
Dravet syndrom
Phase 3 data due 3Q 2017.
ZX008 - (Study 1502)
Dravet syndrom
Phase 3 to be initiated by ZGNX once partner is found.
Relday
Schizophrenia
Approved Oct 25 2013
Zohydro ER
Moderate to severe pain
Approved January 30 2015
Abuse deterrent formulations of Zohydro ER
Moderate to severe pain
Phase 3 data due 2Q 2017.
ZX008 - Study 1501
Dravet syndrom

Latest News

  1. Zogenix to Participate in the 2017 RBC Capital Markets Healthcare Conference
  2. Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome
  3. Zogenix to Participate in the Leerink Partners 6th Annual Global Healthcare Conference
  4. ZOGENIX, INC. Files SEC form 8-K, Other Events
  5. Zogenix Announces Issuance of U.S. Patent for ZX008 in Dravet Syndrome
  6. Blog Coverage Novartis Announced Buyback of Shares Worth $5 Billion; Considers Strategic Options for Alcon Division
  7. ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial
  8. Zogenix Announces CFO Transition
  9. ZOGENIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers
  10. Zogenix Announces CFO Transition
  11. ETFs with exposure to Zogenix, Inc. : December 21, 2016
  12. Is Foamix Pharmaceuticals Ltd (FOMX) Going to Burn These Hedge Funds?
  13. Is Zogenix Stock Still a Buy After Soaring in November?
  14. ZOGENIX, INC. Files SEC form 8-K, Other Events
  15. Zogenix Announces New Efficacy and Safety Data for ZX008 in Treatment of Seizures in Lennox Gastaut Syndrome & Dravet Syndrome
  16. Hedge Funds Are Piling Back Into Zogenix, Inc. (ZGNX): Should You Follow?
  17. Earnings Estimates Moving Higher for Zogenix (ZGNX): Time to Buy?
  18. Moving Average Crossover Alert: Zogenix (ZGNX)
  19. New Data on Zogenix’s ZX008 for Lennox Gastaut Syndrome & Dravet Syndrome to be Presented at 70th Annual American Epilepsy Society Meeting
  20. Zogenix to Participate in Oppenheimer Life Sciences Summit 2016